Anti-Viral Effect of an Extract of Ganoderma Lucidum
First Claim
Patent Images
1. A composition comprising:
- a fucose-containing glycoprotein extract of Ganoderma lucidum;
wherein the extract is used to treat an organism having a virus.
1 Assignment
0 Petitions
Accused Products
Abstract
Compositions and methods for the treatment viral infections in organisms, particularly flu virus. The methods and compositions of the disclosure involve the administration to mammals and immune cells of a fucose-containing glycoprotein fraction from Reishi. An extract of G. lucidum induces immune responses that are shown to induce increase survivability in mice injected with lethal does of influenza virus. The effect is increased when the G. lucidum extract is dosed prior to injection of the lethal dose of influenza virus.
-
Citations
14 Claims
-
1. A composition comprising:
-
a fucose-containing glycoprotein extract of Ganoderma lucidum;
wherein the extract is used to treat an organism having a virus. - View Dependent Claims (2, 3, 4, 5)
-
-
6. A composition comprising:
-
at least a fucose-containing glycoprotein fraction of Ganoderma lucidum, wherein at least the fucose-containing glycoprotein fraction is used for the treatment of virus infections in an organism. - View Dependent Claims (7, 8, 9)
-
-
10. A method comprising:
administering to an organism a pharmacologically effective amount of a fucose-containing glycoprotein extract of Ganoderma lucidum to treat virus infections in an organism.
- 11. The method of claim 11, wherein administration of the fucose-containing glycoprotein extract occurs at least prior to the infection of the organism by the virus.
-
14. A kit comprising:
at least a fucose-containing glycoprotein extract of Ganoderma lucidum.
Specification